Literature DB >> 27091143

Osmotic demyelination syndrome: plasmapheresis versus intravenous immunoglobulin?

Kunakorn Atchaneeyasakul1, Anita Tipirneni1, Salomon Gloria1, Andrew C Berry2, Kush Shah3, Dileep R Yavagal1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27091143     DOI： 10.1007/s11739-016-1452-4

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  13 in total

1.  Treatment of central pontine myelinolysis with therapeutic plasmapheresis.

Authors:  D Bibl; C Lampl; C Gabriel; G Jüngling; H Brock; G Köstler
Journal:  Lancet       Date:  1999-04-03       Impact factor: 79.321

2.  Osmotic demyelination syndrome: variable clinical and radiologic response to intravenous immunoglobulin therapy.

Authors:  Santosh B Murthy; Shahram Izadyar; Megha Dhamne; Joseph S Kass; Corey E Goldsmith
Journal:  Neurol Sci       Date:  2012-04-11       Impact factor: 3.307

3.  Treatment of central pontine myelinolysis with plasmapheresis and immunoglobulins in liver transplant patient.

Authors:  Fuat H Saner; Susanne Koeppen; Marco Meyer; Matthias Kohnle; Stefan Herget-Rosenthal; Georgios C Sotiropoulos; Andreas Paul; Arnold Radtke; Massimo Malagó; Christoph E Broelsch
Journal:  Transpl Int       Date:  2007-12-05       Impact factor: 3.782

4.  Best cases from the AFIP: osmotic demyelination syndrome.

Authors:  Stephanie A Howard; Justine A Barletta; Roman A Klufas; Ali Saad; Umberto De Girolami
Journal:  Radiographics       Date:  2009 May-Jun       Impact factor: 5.333

5.  Immunoglobulins are effective in pontine myelinolysis.

Authors:  J Finsterer; E Engelmayer; E Trnka; M Stiskal
Journal:  Clin Neuropharmacol       Date:  2000 Mar-Apr       Impact factor: 1.592

6.  Central pontine and extrapontine myelinolysis in a pediatric patient following rapid correction of hypernatremia.

Authors:  S Mastrangelo; A Arlotta; M G Cefalo; P Maurizi; A Cianfoni; R Riccardi
Journal:  Neuropediatrics       Date:  2009-12-17       Impact factor: 1.947

7.  "Man-in-the-barrel" syndrome as delayed manifestation of extrapontine and central pontine myelinolysis: beneficial effect of intravenous immunoglobulin.

Authors:  Dirk Deleu; Khalid Salim; Boulenouar Mesraoua; Abbas El Siddig; Hassan Al Hail; Yolande Hanssens
Journal:  J Neurol Sci       Date:  2005-10-15       Impact factor: 3.181

8.  Plasmapheresis and Intravenous Immune Globulin Improve Neurologic Outcome of Central Pontine Myelinolysis Occurring Post Orthotopic Liver Transplant.

Authors:  Kyle P Ludwig; Heather F Thiesset; Timothy J Gayowski; Jason J Schwartz
Journal:  Ann Pharmacother       Date:  2011-02       Impact factor: 3.154

9.  Central pontine myelinolysis in liver transplantation.

Authors:  A P Boon; M P Carey; D H Adams; J Buckels; P McMaster
Journal:  J Clin Pathol       Date:  1991-11       Impact factor: 3.411

10.  Plasma exchange successfully treats central pontine myelinolysis after acute hypernatremia from intravenous sodium bicarbonate therapy.

Authors:  Kyung Yoon Chang; In-Hee Lee; Gi Jun Kim; Kangwon Cho; Hoon Suk Park; Hyung Wook Kim
Journal:  BMC Nephrol       Date:  2014-04-04       Impact factor: 2.388
View more
  9 in total

1.  Treatment of the osmotic demyelination syndrome: the earlier the better?

Authors:  Mohamed Osama Hegazi
Journal:  Intern Emerg Med       Date:  2016-10-18       Impact factor: 3.397

2.  Treatment response in osmotic demyelination syndrome presenting as severe parkinsonism, ptosis and gaze palsy.

Authors:  Sanihah Abdul Halim; Nur Aida Mohd Amin
Journal:  BMJ Case Rep       Date:  2018-10-21

Review 3.  Osmotic Demyelination: From an Oligodendrocyte to an Astrocyte Perspective.

Authors:  Charles Nicaise; Catherine Marneffe; Joanna Bouchat; Jacques Gilloteaux
Journal:  Int J Mol Sci       Date:  2019-03-05       Impact factor: 5.923

Review 4.  Effective treatment of osmotic demyelination syndrome with plasmapheresis: a case report and review of the literature.

Authors:  Maheshi Wijayabandara; Shenal Appuhamy; Praveen Weerathunga; Thashi Chang
Journal:  J Med Case Rep       Date:  2021-01-11

5.  Case Series of Osmotic Demyelination Syndrome Treated With Plasmapheresis: Experience From Two Tertiary Hospitals.

Authors:  Kuan Yee Lim; Yuen Kang Chia; Ching Soong Khoo; Hui Jan Tan
Journal:  J Clin Neurol       Date:  2022-01       Impact factor: 3.077

6.  Pediatric osmotic demyelination syndrome in a case of type 1 diabetes mellitus with diabetic ketoacidosis.

Authors:  Ashlesha Chaudhary; Aashutosh Chaudhary; Radhay Shyam Yadav; Yashaswi Shrestha; Ritu Shah
Journal:  Clin Case Rep       Date:  2022-03-19

7.  Plasmapheresis for Extrapontine Myelinolysis: A Case Series and a Literature Review.

Authors:  Devasmitha Wijesundara; Bimsara Senanayake
Journal:  Case Rep Neurol       Date:  2022-02-15

8.  Polyradiculitis and encephalomyelitis in the same patient following a SARS-CoV-2 vaccination.

Authors:  Josef Finsterer
Journal:  Neurol Res Pract       Date:  2022-03-28

9.  Osmotic Demyelination Syndrome: Clinical, Neuroimaging Characteristics, and Outcomes in a Series of 18 Cases.

Authors:  Xinhuang Lv; Qian Hong; Xiuxiu Lin; Weian Chen; Yuan Tian
Journal:  Biomed Res Int       Date:  2021-05-28       Impact factor: 3.411
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.